SCHEMBL6573613

SCHEMBL6573613

O=CC1CCC1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1920373 0.82
SCHEMBL1766663 0.82
SCHEMBL19441651 0.80 ADH1A (0.33)
SCHEMBL1921081 0.78
SCHEMBL25238328 0.78
SCHEMBL12252323 0.75
SCHEMBL13560923 0.75
SCHEMBL456403 0.73
SCHEMBL5397792 0.69
SCHEMBL25284873 0.67 ADH1A (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2848617-B1 DIARYL[A, G]QUINOLIZIDINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2022-01-12 EP disclosed
US-9751882-B2 Diaryl[A, G]quinolizidine compound, preparation method therefor, pharmaceutical composition, and uses thereof KINGSOUND & PARTNER (CN) 2017-09-05 US disclosed
US-20150141419-A1 DIARYL[A, G]QUINOLIZIDINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2015-05-21 US disclosed
EP-2848617-A1 DIARYL[A, G]QUINOLIZIDINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2015-03-18 EP disclosed
EP-2497475-A1 Treatment of laminitis with platelet aggregation inhibitors Dussler, Sabine (DE) 2012-09-12 EP disclosed
CN-100369896-C Cyclic amine compound SANKYO CO (JP) 2008-02-20 CN disclosed
CN-1192019-C Cyclic amine derivatives SANKYO CO (JP) 2005-03-09 CN disclosed
EP-0934928-B1 CYCLIC AMINE DERIVATIVES SANKYO CO (JP) 2004-10-13 EP disclosed
US-6610708-B1 Anticoagulants SANKYO COMPANY, LIMITED (JP) 2003-08-26 US disclosed
CN-1107502-C Preparation method for medicinal composition containing hydrogenated pyridine derivative as active components SANKYO CO (JP) 2003-05-07 CN disclosed
US-6087379-A AN ANTICOAGULANT FOR THE TREATMENT AND PREVENTION OF DISEASES AS EMBOLISM, THROMBOSIS OR ARTERIOSCLEROSIS SANKYO COMPANY, LIMITED (JP) 2000-07-11 US disclosed
EP-0934928-A1 CYCLIC AMINE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1999-08-11 EP disclosed
CN-1217186-A Preparation method for medicinal composition containing hydrogenated pyridine derivative as active components SANKYO CO (JP) 1999-05-26 CN disclosed
CN-1041730-C Process for preparing hydrogenated pyridine derivatives SANKYO CO (JP) 1999-01-20 CN disclosed
US-5861429-A MITICIDES AND ANTHELMINTICS SANKYO COMPANY, LIMITED (JP) 1999-01-19 US disclosed
EP-0765879-A1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests SANKYO COMPANY LIMITED (JP) 1997-04-02 EP disclosed
US-5436242-A Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof for inhibiting blood platelet aggregation SANKYO COMPANY, LIMITED (JP) 1995-07-25 US disclosed
US-5288726-A Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation UBE INDUSTRIES LIMITED (JP) 1994-02-22 US disclosed
CN-1074446-A Hydroxypyridine Derivatives SANKYO CO (JP) 1993-07-21 CN disclosed
EP-0542411-A2 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation Sankyo Company Limited (JP) 1993-05-19 EP disclosed